# GSE160543 Pathway Analysis Summary

## Dataset
- Species: Rattus norvegicus
- Tissue: dorsal root ganglia (DRG)
- Comparison: Oxaliplatin vs Vehicle
- Method: DESeq2-ranked gene statistics followed by fgsea Hallmark enrichment

## Main enriched transcriptional programs

Strong positive enrichment was observed for:

| Program | NES | Interpretation |
|---|---:|---|
| G2M checkpoint | ~2.90 | Cell-cycle-associated transcriptional program |
| E2F targets | ~2.77 | Proliferation/cell-cycle regulatory program |
| Mitotic spindle | ~2.26 | Mitotic machinery-related transcription |
| Interferon alpha response | ~2.22 | Immune-associated response |
| Interferon gamma response | ~2.19 | Immune-associated response |
| p53 pathway | ~2.04 | Stress/checkpoint response |
| TNFA signaling via NF-kB | ~1.69 | Inflammatory signaling |
| IL6/JAK/STAT3 signaling | ~1.61 | Cytokine-associated signaling |

## Interpretation

The results support a model of oxaliplatin-associated bulk DRG transcriptional remodeling involving two major biological programs:

1. Cell-cycle/stress-associated transcriptional programs
2. Immune-inflammatory transcriptional programs

These findings should not be interpreted as evidence of neuronal cell-cycle re-entry. The analysis reflects expression changes in bulk DRG tissue containing multiple cell populations.

## Next analysis steps

- GO Biological Process enrichment
- GSVA pathway scoring at sample level
- Candidate gene evaluation for cell-cycle and inflammatory programs
- Integration with neuropathy comparison dataset
